Becker's Healthcare April 29, 2024
Paige Twenter

Pfizer’s first FDA-approved gene therapy is one of the most expensive medications in the U.S.

On April 26, Beqvez (fidanacogene elaparvovec-dzkt) won approval to treat some adults with moderate-to-severe hemophilia B. The drugmaker set the list price at $3.5 million,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma / Biotech
Medical device instructions need a rewrite, APIC says
FDA approves Amgen's treatment for most deadly form of lung cancer
Karius snares FDA breakthrough tag for genomic infectious disease blood test
FDA report highlights need to improve diversity in clinical trials
US Pharma and Biotech Summit 2024: Artificial Intelligence and Machine Learning Through the Eyes of the FDA

Share This Article